On ECHEMI
Home > Drugs > Primary chronic angle-closure glaucoma
Primary chronic angle-closure glaucoma
Primary chronic angle-closure glaucoma is a type of glaucoma caused by reasons that are not yet fully understood, which leads to sudden or progressive closure of the anterior chamber angle, obstruction of the drainage of aqueous humor by the peripheral iris meshwork, and a sudden or progressive increase in intraocular pressure. In the 19th century, many ophthalmologists discovered that shallow anterior chamber is closely related to acute glaucoma. Curran first discovered that many of these cases could be successfully treated with peripheral iridectomy. Based on the above findings, many scholars proposed that the occurrence of this type of glaucoma may be related to pupillary block based on clinical observations and the effect of peripheral iridectomy in treating this type of glaucoma.
  • Site of disease:

    Eye
  • Infectious :

    Not contagious
  • Frequent population:

    The incidence rate for people over 40 years old is about 1% to 2%.
  • Related symptoms:

    Increased intraocular pressure Iris vision Dizziness Headache Narrowed visual field
  • Concurrent disease:

Related Drugs
Timolol Maleate Eye Drops
Indication: It has a good effect of reducing intraocular pressure in primary open-angle glaucoma. For some secondary glaucoma, ocular hypertension, some primary angle-closure glaucoma and other glaucoma that are ineffective with other drugs and surgery, the addition of this product to the eye drops can further enhance the effect of reducing intraocular pressure.
Manufacturer:

THE Central Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.